Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gova/b alloantigen system on human platelets.

J G Kelton1, J W Smith, P Horsewood

  • 1Department of Medicine, McMaster Medical Centre, Hamilton, Ontario, Canada.

Blood
|June 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey.

Journal of thrombosis and haemostasis : JTH·2014
Same author

FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia.

Journal of thrombosis and haemostasis : JTH·2013
Same author

A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia.

Journal of thrombosis and haemostasis : JTH·2012
Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026
Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
Same journal

ELISA-negative HIT: antibody recognition and relevance.

Blood·2026
Same journal

EBV and immunodeficiency: the odd couple drawn to the brain.

Blood·2026
Same journal

A bone to pick with ferric carboxymaltose.

Blood·2026
Same journal

A step toward streamlining HIT diagnosis.

Blood·2026
See all related articles

A novel platelet alloantigen system, Gova/Govb, has been identified on a 175-Kd protein. This discovery advances understanding of platelet transfusion compatibility and alloimmunization.

Area of Science:

  • Immunology
  • Hematology
  • Genetics

Background:

  • Platelet alloantigens are crucial for transfusion compatibility.
  • Alloimmunization can occur following platelet transfusions, complicating treatment.
  • Novel platelet antigens require characterization to improve transfusion strategies.

Purpose of the Study:

  • To describe a newly identified platelet alloantigen system.
  • To characterize the protein carrying the Gova/Govb alloantigens.
  • To determine the inheritance pattern and frequency of these alloantigens.

Main Methods:

  • Radioimmunoprecipitation to identify and characterize the platelet protein.
  • Enzyme immunoassays to test for alloantibody detection.
  • Immunodepletion studies to confirm epitope recognition.

Related Experiment Videos

  • Family and population studies for inheritance and frequency analysis.

    • Main Results:

    • A novel platelet alloantigen system, Gova/Govb, was identified on a 175-Kd protein.
    • Alloantibodies were detected in patients with a history of platelet transfusions.
    • The Gova/Govb antigens are inherited in an autosomal codominant manner.
    • Phenotypic frequencies were Gova/Gova (26%), Gova/Govb (55%), and Govb/Govb (19%).

    Conclusions:

    • The Gova/Govb alloantigen system is associated with a distinct 175-Kd platelet protein.
    • This finding has implications for managing alloimmunization in transfusion medicine.
    • Understanding Gova/Govb inheritance and frequency aids in donor-recipient matching.